The genomic landscape of response to EGFR blockade in colorectal cancer
2015 · Nature · 490 citations
https://doi.org/10.1038/nature14969
M
Mark Sausen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
245
Papers
13.4K
Citations
31
h-index
40
i10-index
Mark Sausen is an academic researcher from Human Genome Sciences (United States). The author has contributed to research in topics: Cancer Genomics and Diagnostics & Genetic factors in colorectal cancer & Cancer Immunotherapy and Biomarkers. The author has an h-index of 31, co-authored 209 publications.
ORCID: 0000-0002-2916-5269Papers by this author
worksClinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients
2015 · Nature Communications · 477 citations
https://doi.org/10.1038/ncomms8686
Homologous Recombination Deficiency: Concepts, Definitions, and Assays
2022 · The Oncologist · 207 citations
https://doi.org/10.1093/oncolo/oyab053
Circulating tumor DNA moves further into the spotlight
2014 · Genome Medicine · 25 citations
https://doi.org/10.1186/gm552
Perioperative nivolumab or nivolumab plus ipilimumab in resectable diffuse pleural mesothelioma: a phase 2 trial and ctDNA analyses
2025 · Nature Medicine · 7 citations
https://doi.org/10.1038/s41591-025-03958-3
Molecular and immunological features associated with long-term benefits in metastatic NSCLC patients undergoing immune checkpoint blockade
2025 · OncoImmunology · 5 citations
https://doi.org/10.1080/2162402x.2025.2469377
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat